EndoProtech's technology facilitates the rapid delivery and long term display of clinically relevant bio-therapeutics on the surface of the vascular endothelium, permitting close monitoring and protection of the vascular surface. The technology shows particular promise in the fields of organ transplantation and invasive cardiovascular surgery. EndoProtech, Inc. develops and commercializes therapies for organ transplantation and invasive cardiovascular surgeryFirm is attempting to commercialize anti-complement therapy for ischemia reperfusion injury.
